Re: CKD Reata / Market Cap
|
4
|
Resverlogix Corp.
|
May 04, 2019 02:07PM
|
Article on MOA of BET inhibition restoring sensitivity to anti-androgen therapy
|
4
|
Zenith Epigenetics
|
Sep 18, 2017 02:21PM
|
Re: Thoughts on China Testing
|
4
|
Resverlogix Corp.
|
Aug 31, 2016 12:03PM
|
Re: Trial
|
4
|
Zenith Epigenetics
|
Sep 08, 2016 11:31AM
|
Re: Resverlogix Commences Phase 3 Clinical Trial BETonMACE With Apabetalone
|
4
|
Resverlogix Corp.
|
Oct 26, 2015 01:41PM
|
Re: Zenith prezzy
|
4
|
Zenith Epigenetics
|
Jun 20, 2017 11:05PM
|
Re: ALP Levels Predict Adverse Cardiovascular Outcomes And Cognitive Impairment In High Risk Patients
|
4
|
Resverlogix Corp.
|
Aug 08, 2019 10:26PM
|
New Published Evidence of Apabetalone’s Beneficial Effects on COVID-19
|
4
|
Resverlogix Corp.
|
Mar 03, 2021 02:28PM
|
Re: … Zack’s analyst report's impact...
|
4
|
Resverlogix Corp.
|
Nov 04, 2015 01:05PM
|
Re: What happens if.....
|
4
|
Resverlogix Corp.
|
Jun 25, 2017 11:33PM
|
Re: New Published Evidence of Apabetalone’s Beneficial Effects on COVID-19
|
4
|
Resverlogix Corp.
|
Mar 03, 2021 02:29PM
|
Re: Q4 2019 Events
|
4
|
Resverlogix Corp.
|
Oct 25, 2019 08:16AM
|
Re: Years ago
|
4
|
Resverlogix Corp.
|
Feb 13, 2020 01:01PM
|
Re: New video
|
4
|
Resverlogix Corp.
|
Aug 03, 2021 10:28AM
|
Re: Another Indication ?
|
4
|
Resverlogix Corp.
|
May 11, 2019 11:32AM
|
Never heard of them
|
4
|
BIOASIS TECHNOLOGIES INC
|
Sep 18, 2016 07:36AM
|
Re: BET inhibition and epilepsy
|
4
|
Resverlogix Corp.
|
Jun 11, 2021 05:52PM
|
Re: BETonMACE Enrollment
|
4
|
Resverlogix Corp.
|
Feb 08, 2019 11:03PM
|
Re: Statistical Considerations
|
4
|
Resverlogix Corp.
|
Mar 09, 2018 11:14AM
|
Re: Since GAC....
|
4
|
Resverlogix Corp.
|
Feb 29, 2020 08:15AM
|